Novo’s newest GLP-1, CagriSema, is the first big test of Novo Nordisk’s future as the leader in the obesity treatment market.

Under the 2022 federal law, drugmakers must pay rebates ... scrutinized over the pricing of its blockbuster diabetes drug Ozempic and weight loss drug Wegovy. The company's top executive was ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

She's going to have good arms!' I was ten years old and standing in my parents' bathroom when I heard my mother say this.

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

According to CMS data, Medicare Part D spending on Ozempic was more than $4.6 billion in 2022. Ozempic has become emblematic of the explosive enthusiasm for GLP-1 medications in the U.S. Danish ...

As Lottie Moss appears on Celebrity Bear Hunt, MOLLY CLAYTON describes the moment she met the younger sister of supermodel ...

In 2022, she admitted to getting liposuction after ... A few months later, Schumer came clean about her Ozempic use on “Watch What Happens Live with Andy Cohen.” “I was one of those people ...

Comedian Amy Schumer revealed that, while she had success using the popular weight loss drug Ozempic, she had to quit taking it due to the side effects.

Ozempic and Wegovy are now two of the biggest ... The Inflation Reduction Act (IRA) of 2022 empowered Medicare to directly negotiate with pharmaceutical companies to try to secure lower prices ...

Unlike other weight-loss medications, Ozempic also improves insulin sensitivity, reduces inflammation, and slows down digestion, leading to more sustainable weight loss.” A 2022 study published ...